TLRY
Tilray Brands Inc. Healthcare - Cannabis Investor Relations →
Tilray Brands Inc. (TLRY) closed at $6.21 as of 2026-03-20, trading 67.3% below its 200-week moving average of $19.02. This places TLRY in the extreme value zone. The stock is currently moving closer to the line, down from -64.2% last week. With a 14-week RSI of 11, TLRY is in oversold territory.
Over the past 14 weeks, down-weeks have had more trading volume than up-weeks (0.43 buyers-vs-sellers ratio). That means when people are active, they're more often selling than buying. Sellers are still more in control than buyers.
Over the past 352 weeks of data, TLRY has crossed below its 200-week moving average 1 time. On average, these episodes lasted 352 weeks.
With a market cap of $724 million, TLRY is a small-cap stock. The company generates a free cash flow yield of 4.3%. Return on equity stands at -84.1%. The stock trades at 0.4x book value.
Share count has increased 98.7% over three years, indicating dilution.
Over the past 6.8 years, a hypothetical investment of $100 in TLRY would have grown to $1, compared to $246 for the S&P 500. TLRY has returned -46.8% annualized vs 14.1% for the index, underperforming the broader market over this period.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: TLRY vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After TLRY Crosses Below the Line?
Across 1 historical episodes, buying TLRY when it crossed below its 200-week moving average produced an average return of -85.0% after 12 months (median -85.0%), compared to +7.0% for the S&P 500 over the same periods. After 24 months, the average return was -63.0% vs +51.0% for the index.
Each line shows $100 invested at the moment TLRY crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
TLRY has crossed below its 200-week MA 1 time
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jun 2019 | Ongoing | 352+ | 93.1% | Ongoing | -98.7% |
Frequently Asked Questions
Is TLRY below its 200-week moving average?
Yes. As of 2026-03-20, Tilray Brands Inc. (TLRY) is trading 67.3% below its 200-week moving average of $19.02. The current price is $6.21.
What is TLRY's 200-week moving average price?
Tilray Brands Inc.'s 200-week moving average is $19.02 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when TLRY drops below its 200-week moving average?
TLRY has crossed below its 200-week moving average 1 time in our data. These episodes lasted 352 weeks on average.
Is TLRY a good value right now?
Here's what our data says about TLRY as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 11 (oversold). Free cash flow yield is 4.3%. Return on equity is -84.1%. Price-to-book is 0.4x. This is not a buy or sell recommendation — always do your own research.
How does TLRY compare to the S&P 500?
Over the past 6.8 years, $100 invested in TLRY would have grown to $1, compared to $246 for the S&P 500. That's -46.8% annualized vs 14.1% for the index. TLRY has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20